Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Update

Check-Cap Ltd. (NASDAQ:CHEK) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 242,000 shares, a growth of 108.6% from the February 13th total of 116,000 shares. Currently, 5.5% of the shares of the stock are short sold. Based on an average daily volume of 1,350,000 shares, the short-interest ratio is currently 0.2 days.

Check-Cap Stock Performance

Shares of Check-Cap stock traded down $0.02 during midday trading on Friday, hitting $0.76. 6,147 shares of the company traded hands, compared to its average volume of 850,579. The firm’s fifty day moving average price is $1.04 and its 200-day moving average price is $1.18. The stock has a market cap of $4.43 million, a price-to-earnings ratio of -0.25 and a beta of 0.19. Check-Cap has a 12 month low of $0.56 and a 12 month high of $3.45.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on Check-Cap in a research note on Sunday, March 9th. They issued a “sell” rating on the stock.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.